PELP1 Monoklonaler Antikörper

PELP1 Monoklonal Antikörper für WB, IHC, IF-P, IF-Fro, FC (Intra), Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human

Anwendung

WB, IHC, IF-P, IF-Fro, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1B11E4

Kat-Nr. : 67050-1-PBS

Synonyme

1B11E4, HMX3, MNAR, Modulator of non-genomic activity of estrogen receptor, Proline-, glutamic acid- and leucine-rich protein 1



Geprüfte Anwendungen

Produktinformation

67050-1-PBS bindet in WB, IHC, IF-P, IF-Fro, FC (Intra), Indirect ELISA PELP1 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen PELP1 fusion protein Ag25729
Vollständiger Name proline, glutamate and leucine rich protein 1
Berechnetes Molekulargewicht 1130 aa, 120 kDa
Beobachtetes Molekulargewicht 160 kDa
GenBank-ZugangsnummerBC069058
Gene symbol PELP1
Gene ID (NCBI) 27043
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

PELP1 was first identified as a 160 kDa protein in a screen for Src homology 2 (SH2) domain-binding proteins. PELP1 is overexpressed in 60-80% of breast tumors and plays important roles in both ER genomic and non-genomic signaling. In vivo, PELP1 subcellular localization is primarily nuclear in normal breast tissue, but it is localized to the cytoplasm in about 40% of invasive breast tumors. In the nucleus, PELP1 interacts with a number of transcription factors. The proto-oncogenic functions of PELP1 involve different cellular processes including epigenetic modifications leading to ER transactivation and breast cancer progression. Furthermore, PELP1 activates kinase cascades in the cytoplasm such as MAPK activation via c-Src and PI3K signaling.